Research & Clinical Trials

Islet Transplantation in Type 1 Diabetes with LEA29Y (Belatacept) Maintenance Therapy (CIT-04) - Closed to Enrollment
Principal Investigator: Christian Larsen, MD, DPhil
Study Coordinators: Jennifer Hutchinson, RN and Keshawna Sherer, RN

Islet Transplantation versus Standard Medical Therapy in Type 1 Diabetic Kidney Allograft Recipients (CIT-06) - Enrolling
Principal Investigator: Christian Larsen, MD, DPhil
Study Coordinators: Jennifer Hutchinson, RN and Keshawna Sherer, RN

Islet Transplanation in Type 1 Diabetes (CIT-07) - Closed to Enrollment
Principal Investigator: Christian Larsen, MD, DPhil
Study Coordinators: Jennifer Hutchinson, RN and Keshawna Sherer, RN

Islet Transplantation in Type 1 Diabetics using efalizumab (Raptiva®) maintenance therapy - Closed to Enrollment
Principal Investigator: Christian Larsen, MD, DPhil
Study Coordinators: Jennifer Hutchinson, RN and Keshawna Sherer, RN

Islet Transplantation in Type 1 Diabetic Patients using the Edmonton Steroid Free Immunosuppression - Closed to Enrollment
Principal Investigator: Christian Larsen, MD, DPhil
Study Coordinators: Jennifer Hutchinson, RN and Keshawna Sherer, RN

Collaborative Islet Transplant Registry - Enrolling
Investigator: Nicole Turgeon, MD
Coordinators: Jennifer Hutchinson, RN and Keshawna Sherer, RN

If you are interested in learning more about these or other Emory Transplant Center Clinical Research projects, please call the ETC Clinical Research Program at 404-712-1114 to speak with one of our research coordinators.

Emory Transplant Center